Acute Urinary Retention Rates in the General Male Population and in Adult Men With Lower Urinary Tract Symptoms Participating in Pharmacotherapy Trials: A Literature Review.

@article{Oelke2015AcuteUR,
  title={Acute Urinary Retention Rates in the General Male Population and in Adult Men With Lower Urinary Tract Symptoms Participating in Pharmacotherapy Trials: A Literature Review.},
  author={Matthias Oelke and Mark J. Speakman and François Desgrandchamps and Charalampos Mamoulakis},
  journal={Urology},
  year={2015},
  volume={86 4},
  pages={654-65}
}
Despite proven efficacy, antimuscarinics are not frequently used for treating lower urinary tract symptoms in adult men, due to the perception of an increased risk of acute urinary retention (AUR). Men treated with α-blockers, 5α-reductase inhibitors, or their combinations have lower AUR incidence rates than the general symptomatic population. In the selected study population in this review (men with post-void residuals ≤200 mL), the risk of AUR with antimuscarinics with and/or without… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 1 time over the past 90 days. VIEW TWEETS
4 Citations
51 References
Similar Papers

References

Publications referenced by this paper.
Showing 1-10 of 51 references

Combination therapy with solifenacin and tamsulosin OCAS in a single tablet for lower urinary track symptoms in men: efficacy and safety results from the randomised controlled NEPTUNE trial

  • P van Kerrebroeck, C Chapple, T Drogendijk
  • Eur Urol
  • 2013

Efficacy and safety of solifenacin plus tamsulosin OCAS in men with voiding and storage LUTS: results from a phase 2, dose-finding study (SATURN)

  • PEV van Kerrebroeck, F Haab, JC Angulo
  • Eur Urol
  • 2013
2 Excerpts

Similar Papers

Loading similar papers…